Agilent Technologies Sees Unusually High Options Volume (NYSE:A)

Agilent Technologies, Inc. (NYSE:AGet Rating) saw unusually large options trading activity on Tuesday. Traders purchased 1,630 call options on the company. This represents an increase of 56% compared to the typical daily volume of 1,042 call options.

Insider Transactions at Agilent Technologies

In related news, SVP Michael Tang sold 7,545 shares of Agilent Technologies stock in a transaction dated Tuesday, November 22nd. The shares were sold at an average price of $153.90, for a total value of $1,161,175.50. Following the sale, the senior vice president now directly owns 46,499 shares in the company, valued at approximately $7,156,196.10. The sale was disclosed in a legal filing with the SEC, which is available at the SEC website. In other Agilent Technologies news, SVP Michael Tang sold 7,545 shares of the firm’s stock in a transaction dated Tuesday, November 22nd. The shares were sold at an average price of $153.90, for a total transaction of $1,161,175.50. Following the transaction, the senior vice president now owns 46,499 shares of the company’s stock, valued at approximately $7,156,196.10. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. Also, VP Padraig Mcdonnell sold 2,103 shares of Agilent Technologies stock in a transaction that occurred on Wednesday, September 28th. The stock was sold at an average price of $122.89, for a total transaction of $258,437.67. Following the completion of the transaction, the vice president now directly owns 13,217 shares in the company, valued at approximately $1,624,237.13. The disclosure for this sale can be found here. In the last three months, insiders have sold 174,326 shares of company stock worth $26,474,537.

Institutional Investors Weigh In On Agilent Technologies

Several institutional investors and hedge funds have recently made changes to their positions in the company. EverSource Wealth Advisors LLC lifted its position in Agilent Technologies by 34.8% during the 3rd quarter. EverSource Wealth Advisors LLC now owns 298 shares of the medical research company’s stock worth $37,000 after buying an additional 77 shares in the last quarter. Baker Avenue Asset Management LP lifted its position in Agilent Technologies by 0.3% during the 2nd quarter. Baker Avenue Asset Management LP now owns 28,215 shares of the medical research company’s stock worth $3,351,000 after buying an additional 78 shares in the last quarter. King Luther Capital Management Corp lifted its position in Agilent Technologies by 0.3% during the 3rd quarter. King Luther Capital Management Corp now owns 24,625 shares of the medical research company’s stock worth $2,993,000 after buying an additional 78 shares in the last quarter. CWM LLC lifted its position in Agilent Technologies by 1.7% during the 2nd quarter. CWM LLC now owns 4,890 shares of the medical research company’s stock worth $581,000 after buying an additional 81 shares in the last quarter. Finally, Massmutual Trust Co. FSB ADV lifted its position in Agilent Technologies by 1.6% during the 2nd quarter. Massmutual Trust Co. FSB ADV now owns 5,332 shares of the medical research company’s stock worth $633,000 after buying an additional 83 shares in the last quarter.

Agilent Technologies Trading Down 1.0 %

Shares of Agilent Technologies stock opened at $155.35 on Thursday. The firm has a market capitalization of $45.99 billion, a PE ratio of 37.25, a price-to-earnings-growth ratio of 2.65 and a beta of 1.06. The company has a debt-to-equity ratio of 0.54, a current ratio of 1.94 and a quick ratio of 1.41. The company’s fifty day moving average price is $133.55 and its two-hundred day moving average price is $128.29. Agilent Technologies has a 52-week low of $112.52 and a 52-week high of $162.62.

Agilent Technologies (NYSE:AGet Rating) last announced its quarterly earnings results on Monday, November 21st. The medical research company reported $1.53 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.39 by $0.14. The firm had revenue of $1.85 billion for the quarter, compared to analyst estimates of $1.76 billion. Agilent Technologies had a net margin of 18.31% and a return on equity of 30.55%. The business’s revenue for the quarter was up 11.4% on a year-over-year basis. During the same quarter in the previous year, the firm posted $1.21 EPS. On average, analysts expect that Agilent Technologies will post 5.48 EPS for the current year.

Agilent Technologies Increases Dividend

The company also recently announced a quarterly dividend, which will be paid on Wednesday, January 25th. Stockholders of record on Tuesday, January 3rd will be paid a $0.225 dividend. This represents a $0.90 annualized dividend and a dividend yield of 0.58%. The ex-dividend date of this dividend is Friday, December 30th. This is an increase from Agilent Technologies’s previous quarterly dividend of $0.21. Agilent Technologies’s payout ratio is currently 20.14%.

Wall Street Analysts Forecast Growth

Several research firms recently commented on A. Jefferies Financial Group raised their price target on shares of Agilent Technologies from $158.00 to $168.00 in a report on Tuesday. SVB Leerink raised their price target on shares of Agilent Technologies from $145.00 to $160.00 and gave the stock an “outperform” rating in a report on Tuesday. Credit Suisse Group began coverage on shares of Agilent Technologies in a report on Wednesday, August 24th. They set an “outperform” rating and a $165.00 price target for the company. Cowen raised their price target on shares of Agilent Technologies from $160.00 to $168.00 in a report on Tuesday. Finally, Cowen raised their price target on shares of Agilent Technologies from $160.00 to $168.00 in a report on Tuesday. Four equities research analysts have rated the stock with a hold rating, nine have given a buy rating and one has given a strong buy rating to the stock. Based on data from MarketBeat.com, Agilent Technologies has an average rating of “Moderate Buy” and a consensus target price of $157.00.

Agilent Technologies Company Profile

(Get Rating)

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; vacuum pumps, and measurement technologies.

Further Reading

Receive News & Ratings for Agilent Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilent Technologies and related companies with MarketBeat.com's FREE daily email newsletter.